Erratum: Hypothyroidism and risk of mild cognitive impairment in elderly persons: A population-based study (JAMA Neurology (2014) 71, 2 (201-207) DOI:10.1001/jamaneurol.2013.5402);Hypothyroidism and risk of mild cognitive impairment in elderly persons a population-based study

JAMA Neurology

Volumn 71, Issue 2, 2014, Pages 201-207

  Parsaik, Ajay K ^a,b   Singh, Balwinder ^b,c   Roberts, Rosebud O ^b   Pankratz, Shane ^b   Edwards, Kelly K ^b   Geda, Yonas E ^d   Gharib, Hossein ^b   Boeve, Bradley F ^b   Knopman, David S ^b   Petersen, Ronald C ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b MAYO CLINIC   (United States)

^c UND School of Medicine & Health Sciences Southeast Campus   (United States)

^d MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4; THYROID HORMONE;

AGE; AGED; AMNESIA; ARTICLE; BODY MASS; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; DEPRESSION; DIABETES MELLITUS; DISEASE ASSOCIATION; EDUCATIONAL STATUS; FEMALE; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; HYPOTHYROIDISM; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TEST; POPULATION RESEARCH; PRIORITY JOURNAL; RISK FACTOR; SEX; SUBCLINICAL HYPOTHYROIDISM; UNITED STATES;

AGED; AGED, 80 AND OVER; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPOTHYROIDISM; MALE; MILD COGNITIVE IMPAIRMENT; POPULATION SURVEILLANCE; REGISTRIES; RISK FACTORS;

EID: 84893874527     PISSN: 21686149     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaneurol.2014.2274     Document Type: Erratum

References (52)

1. Tan ZS, Beiser A, Vasan RS, et al. Thyroid function and the risk of Alzheimer disease: the Framingham Study. Arch Intern Med. 2008;168(14):1514- 1520.
2. Knopman DS, DeKosky ST, Cummings JL, et al. Practice parameter: diagnosis of dementia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001;56(9):1143-1153.
3. Baldini IM, Vita A, Mauri MC, et al. Psychopathological and cognitive features in subclinical hypothyroidism. Prog Neuropsychophar-macol Biol Psychiatry. 1997;21(6):925-935.
4. Haggerty JJ Jr, Garbutt JC, Evans DL, et al. Subclinical hypothyroidism: a review of neuropsychiatric aspects. Int J Psychiatry Med. 1990;20(2):193-208.
5. Jensovsky J, Ruzicka E, Spackova N, Hejdukova B. Changes of event related potential and cognitive processes in patients with subclinical hypothyroidism after thyroxine treatment. Endocr Regul. 2002;36(3):115-122.
6. Monzani F, Del Guerra P, Caraccio N, et al. Subclinical hypothyroidism: neurobehavioral features and beneficial effect of L-thyroxine treatment. Clin Investig. 1993;71(5):367-371.
7. Resta F, Triggiani V, Barile G, et al. Subclinical hypothyroidism and cognitive dysfunction in the elderly. Endocr Metab Immune Disord Drug Targets. 2012;12(3):260-267.
8. Wu T, Flowers JW, Tudiver F, Wilson JL, Punyasavatsut N. Subclinical thyroid disorders and cognitive performance among adolescents in the United States. BMC Pediatr. 2006;6:12. doi 10.1186/1471-2431-6-12.
9. de Jongh RT, Lips P, van Schoor NM, et al. Endogenous subclinical thyroid disorders, physical and cognitive function, depression, and mortality in older individuals. Eur J Endocrinol. 2011;165(4):545-554.
10. Gussekloo J, van Exel E, de Craen AJ, Meinders AE, Frölich M, Westendorp RG. Thyroid status, disability and cognitive function, and survival in old age. JAMA. 2004;292(21):2591-2599.
11. Jorde R, Waterloo K, Storhaug H, Nyrnes A, Sundsfjord J, Jenssen TG. Neuropsychological function and symptoms in subjects with subclinical hypothyroidism and the effect of thyroxine treatment. J Clin Endocrinol Metab. 2006;91(1):145-153.
12. Lindeman RD, Schade DS, LaRue A, et al. Subclinical hypothyroidism in a biethnic, urban community. J Am Geriatr Soc. 1999;47(6):703-709.
13. Luboshitzky R, Oberman AS, Kaufman N, Reichman N, Flatau E. Prevalence of cognitive dysfunction and hypothyroidism in an elderly community population. Isr J Med Sci. 1996;32(1):60-65.
14. Park YJ, Lee EJ, Lee YJ, et al. Subclinical hypothyroidism (SCH) is not associated with metabolic derangement, cognitive impairment, depression or poor quality of life (QoL) in elderly subjects. Arch Gerontol Geriatr. 2010;50(3):e68-e73. doi 10.1016/j.archger.2009.05.015.
15. Roberts LM, Pattison H, Roalfe A, et al. Is subclinical thyroid dysfunction in the elderly associated with depression or cognitive dysfunction? Ann Intern Med. 2006;145(8):573-581.
16. Breteler MM, van Duijn CM, Chandra V, et al; EURODEM Risk Factors Research Group. Medical history and the risk of Alzheimer's disease: a collaborative re-analysis of case-control studies. Int J Epidemiol. 1991;20(suppl 2):S36-S42.
17. Erlanger DM, Kutner KC, Jacobs AR. Hormones and cognition: current concepts and issues in neuropsychology. Neuropsychol Rev. 1999;9(4):175-207.
18. Osterweil D, Syndulko K, Cohen SN, et al. Cognitive function in non-demented older adults with hypothyroidism. J Am Geriatr Soc. 1992;40(4):325-335.
19. van Boxtel MP, Menheere PP, Bekers O, Hogervorst E, Jolles J. Thyroid function, depressed mood, and cognitive performance in older individuals: the Maastricht Aging Study. Psychoneuroendocrinology. 2004;29(7):891-898.
20. Kim JM, Stewart R, Kim SY, et al. Thyroid stimulating hormone, cognitive impairment and depression in an older Korean population. Psychiatry Invest. 2010;7(4):264-269.
21. Kramer CK, von Muhlen D, Kritz-Silverstein D, Barrett-Connor E. Treated hypothyroidism, cognitive function, and depressed mood in old age: the Rancho Bernardo Study. Eur J Endocrinol. 2009;161(6):917-921.
22. Lopez O, Huff FJ, Martinez AJ, Bedetti CD. Prevalence of thyroid abnormalities is not increased in Alzheimer's disease. Neurobiol Aging. 1989;10(3):247-251.
23. Shalat SL, Seltzer B, Pidcock C, Baker EL Jr. Risk factors for Alzheimer's disease: a case-control study. Neurology. 1987;37(10):1630-1633.
24. Small GW, Matsuyama SS, Komanduri R, Kumar V, Jarvik LF. Thyroid disease in patients with dementia of the Alzheimer type. J Am Geriatr Soc. 1985;33(8):538-539.
25. Gauthier S, Reisberg B, Zaudig M, et al; International Psychogeriatric Association Expert Conference on mild cognitive impairment. Mild cognitive impairment. Lancet. 2006;367(9518):1262-1270.
26. Petersen RC. Clinical practice: mild cognitive impairment. N Engl J Med. 2011;364(23):2227-2234.
27. Petersen RC, Roberts RO, Knopman DS, et al. Mild cognitive impairment: ten years later. Arch Neurol. 2009;66(12):1447-1455.
28. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56(3):303-308.
29. Petersen RC, Stevens JC, Ganguli M, Tangalos EG, Cummings JL, DeKosky ST. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001;56(9):1133-1142.
30. Roberts RO, Geda YE, Knopman DS, et al. The Mayo Clinic Study of Aging: design and sampling, participation, baseline measures and sample characteristics. Neuroepidemiology. 2008;30(1):58-69.
31. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993;43(11):2412-2414.
32. Pfeffer RI, Kurosaki TT, Harrah CH Jr, Chance JM, Filos S. Measurement of functional activities in older adults in the community. J Gerontol. 1982;37(3):323-329.
33. Wechsler D. Manual for the Wechsler Memory Scale-Revised. New York, NY: Psychological Corp; 1987.
34. Rey A. L'examen Clinique en Psychologie. Paris, France: Presses Universitaires de France; 1964.
35. Reitan RM. Validity of the Trail-Making Test as an indication of organic brain damage. Percept Mot Skills. 1958;8:271-276.
36. Wechsler D. Wechsler Adult Intelligence Scale-Revised. San Antonio, TX: Psychological Corp; 1981.
37. Kaplan E G H, Weintraub S. The Boston Naming Test. 2nd ed. Boston, MA: Lea and Fabiger; 1978.
38. Strauss E S E, Spreen O. A Compendium of Neuropsychological Tests. New York, NY: Oxford University Press; 2006.
39. Smith GE, Ivnik RJ, Malec JF, Kokmen E, Tangalos EG, Kurland LT. Mayo's Older Americans Normative Studies (MOANS): factor structure of a core battery. Psychol Assess. 1992;4(3):382-390.
40. Kokmen E, Smith GE, Petersen RC, Tangalos E, Ivnik RC. The Short Test of Mental Status: correlations with standardized psychometric testing. Arch Neurol. 1991;48(7):725-728.
41. Petersen RC, Roberts RO, Knopman DS, et al; Mayo Clinic Study of Aging. Prevalence of mild cognitive impairment is higher in men. Neurology. 2010;75(10):889-897.
42. Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004;256(3):183-194.
43. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. ed 4. Washington, DC: American Psychiatric Association; 1994.
44. Melton LJ III. History of the Rochester Epidemiology Project. Mayo Clinic Proc. 1996;71(3):266-274.
45. World Health Organization. International Classification of Diseases, Ninth Revision (ICD-9). Geneva, Switzerland: World Health Organization; 1977.
46. H-ICDA. Hospital Adaptation of ICDA. 2nd ed. Ann Arbor: Michigan Commission on Professional and Hospital Activities; 1973.
47. Beck AT, Steer RA, Ball R, Ranieri W. Comparison of Beck Depression Inventories-IA and -II in psychiatric outpatients. J Pers Assess. 1996;67(3):588-597.
48. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res. 1990;31(3):545-548.
49. Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87:489-499.
50. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med. 2000;160(4):526-534.
51. van der Cammen TJ, Mattace-Raso F, van Harskamp F, de Jager MC. Lack of association between thyroid disorders and Alzheimer's disease in older persons: a cross-sectional observational study in a geriatric outpatient population. J Am Geriatr Soc. 2003;51(6):884. doi: 10.1046/j.1365-2389.2003.51278.x.
52. St Sauver JL, Grossardt BR, Leibson CL, Yawn BP, Melton LJ III, Rocca WA. Generalizability of epidemiological findings and public health decisions: an illustration from the Rochester Epidemiology Project. Mayo Clinic Proc. 2012;87(2):151-160.